Posts by eva:

Everest Medicines’ New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access

HONG KONG, Aug 14, 2025 – (ACN Newswire via SeaPRwire.com) – Everest Medicines (HKEX 1952.HK, “Everest”) today announced that the Taiwan Food and Drug Administration (TFDA) has officially accepted the New Drug Application (NDA) for VELSIPITY(R) (etrasimod) for the treatment of patients with moderately to severely active ulcerative colitis (UC). Building on prior approvals in Singapore, […]

Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC

HONG KONG, Aug 15, 2025 – (ACN Newswire via SeaPRwire.com) – Everest Medicines today announced that etrasimod (VELSIPITY(R)) has been included in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults (the “Updated Guidelines”). Etrasimod, an S1P receptor modulator, is recommended for the induction of remission in patients with moderately to severely active UC and for […]

Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC

HONG KONG, Aug 15, 2025 – (ACN Newswire via SeaPRwire.com) -?Everest Medicines today announced that etrasimod (VELSIPITY(R)) has been included in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults (the ?Updated Guidelines?). Etrasimod, an S1P receptor modulator, is recommended for the induction of remission in patients with moderately to severely active UC and for […]

Everest Medicines’ New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access

HONG KONG, Aug 14, 2025 – (ACN Newswire via SeaPRwire.com) – Everest Medicines (HKEX 1952.HK, “Everest”) today announced that the Taiwan Food and Drug Administration (TFDA) has officially accepted the New Drug Application (NDA) for VELSIPITY(R) (etrasimod) for the treatment of patients with moderately to severely active ulcerative colitis (UC). Building on prior approvals in Singapore, […]

Yuexiu REIT Maintains Overall Operational Stability, Achieves Revenue of Over RMB966 Million

HONG KONG, Aug 14, 2025 – (ACN Newswire via SeaPRwire.com) – Yuexiu Real Estate Investment Trust (“Yuexiu REIT”, together with Yuexiu REIT Asset Management Limited, collectively known as the “REIT”; stock code: 405) announced its interim results for the six months ended 30 June 2025. Yuexiu REIT Management Team: Chairman and Non-Executive Director Mr. JIANG […]

OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively

Results Highlights: – Revenue reached US$83.6 million, a year-on-year increase of 5.9%.– Sales volume reached 919,000 units, of which 779,000 units were proprietary products, representing a year-on-year increase of 8.6%.– Profit attributable to owners of the company increased by 5.1% year-on-year to US$19.8 million.– Core operating profit amounted to US$15.1 million, an increase of 11.4% […]

NMPA Accepted Essex’s Biologics License Application for EB12-20145P (HLX04-O) for the Treatment of Wet Age-Related Macular Degeneration

HONG KONG, Aug 13, 2025 – (ACN Newswire via SeaPRwire.com) – Essex Bio-Technology Limited (“Essex” or the “Group”, Stock Code: 1061.HK) is pleased to announce that a Biologics License Application (“BLA”) for EB12-20145P (HLX04-O), a recombinant anti-VEGF humanized monoclonal antibody injection, has recently been accepted by the Centre for Drug Evaluation (“CDE”) of the National Medical […]

Re-opening of Food Expo and concurrent fairs

HONG KONG, Aug 14, 2025 – (ACN Newswire via SeaPRwire.com) – Following the lifting of the Black Rainstorm Warning Signal at 11:10am, the Food Expo, Beauty & Wellness Expo, Home Delights Expo, Food Expo PRO and Hong Kong International Tea Fair will reopen at 1:10pm. The Food Expo, Beauty & Wellness Expo, Home Delights Expo […]

WL Delicious Announced 2025 Interim Results

HONG KONG, Aug 14, 2025 – (ACN Newswire via SeaPRwire.com) – Weilong Delicious Global Holdings Ltd (“WL Delicious” or the “Company”) and together with its subsidiaries (the “Group”) (Hong Kong stock code: 9985.HK) announced its unaudited interim results for the six months ended 30 June 2025 (the “Reporting Period”). RMB For the 6 months ended 30 […]

Cryofocus Medtech Achieves Record Interim Results with 162% Revenue Surge Driven by Respiratory Intervention Products

HONG KONG, Aug 11, 2025 – (ACN Newswire via SeaPRwire.com) – Cryofocus Medtech (Shanghai) Co., Ltd. (“Cryofocus” or the “Company,” Stock Code: 6922.HK), a global innovator in minimally invasive interventional cryotherapy, last friday announced its unaudited interim results for the six months ended June 30, 2025. The Company demonstrated robust growth momentum and significant operational […]

Formerra Becomes North American Distributor for Syensqo PVDF

ROMEOVILLE, IL, Aug 12, 2025 – (ACN Newswire via SeaPRwire.com) – Formerra, a leader in performance materials distribution, has signed an agreement with Syensqo to distribute its Solef® Polyvinylidene Fluoride (PVDF) materials in North America. The agreement expands access to this critical material known for its combination of chemical resistance and flexibility. Solef® PVDF joins a growing list […]

GEON Performance Solutions Achieves Great Place to Work Recognition Globally Second Year in a Row

WESTLAKE, OH, Aug 12, 2025 – (ACN Newswire via SeaPRwire.com) – GEON® Performance Solutions, a global leader in the formulation, development and manufacture of performance polymer solutions, announced today that it received Great Place To Work® (GPTW) certifications for its USA, Canada, Mexico and China locations. Since partnering with GPTW in 2021, GEON’s cultural and sustainability vision is […]